Mission

The mission of Child Health Research Foundation is to improve child health in Bangladesh and around the world by facilitating appropriate policy decisions through research and advocacy.

The idea for setting up CHRF came from the realization of the founding group of researchers that developing countries like Bangladesh often lack the evidence needed for rational and timely policy decisions due to inadequate and improper use of limited resources. Scarcity of evidence, in turn, discourages the investment in child health. CHRF works to make sure that evidence about disease burden and causes is generated through high quality research conducted using limited resources.

In addition to research, CHRF also works with other non-profit hospitals to facilitate low cost diagnostic services for poor patients to improve child health while simultaneously collective valuable evidence for policy designs. Through an association with the Department of Microbiology at Dhaka Shishu Hospital and through a consortium of urban and rural hospitals, CHRF has access to research facilities that enables it to contribute to scientific and medical knowledge and their applications in South Asia to improve public health approaches.

Through these activities, CHRF aims to break the vicious cycle that limits the potential of limited resources and convert it to a virtuous cycle by making appropriate use of limited resources, produce evidence, facilitate evidence-based policy decisions, shorten the time lag between evidence and implementation and generate interest for increased and sustained investments in child health. Finally, CHRF works to contribute in reducing child mortality by creating awareness and advocating for appropriate care and care-seeking behavior, ensuring rational treatments, and evidence-based preventive programs.


Our Collaborators

 Collaborators of Child Health Research Foundation include Bill & Melinda Gates Foundation; World Health Organization (WHO); Wellcome Trust; Institute of Tropical Medicine, Nagasaki University; Johns Hopkins University; Nuffield Department of Medicine (Infectious Disease & Microbiology Group), Oxford University; Centre for Disease Control (CDC); icddr,b; Gavi, the Vaccine Alliance; GlaxoSmithKline; Foundation Merieux; United States Agency for International Development (USAID); Beximco Pharmaceuticals Ltd.; International Vaccine Institute (IVI).